• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Expression of axl in lung adenocarcinoma and correlation with tumor progression.轴突受体酪氨酸激酶(axl)在肺腺癌中的表达及其与肿瘤进展的相关性。
Neoplasia. 2005 Dec;7(12):1058-64. doi: 10.1593/neo.05640.
2
Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma.受体酪氨酸激酶 Axl 的过表达促进胰腺导管腺癌中肿瘤细胞的侵袭和存活。
Cancer. 2011 Feb 15;117(4):734-43. doi: 10.1002/cncr.25483. Epub 2010 Oct 4.
3
Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL.柳氮磺胺吡啶可抑制表达AXL的肺腺癌细胞的耐药性和侵袭性。
Cancer Res. 2007 Apr 15;67(8):3878-87. doi: 10.1158/0008-5472.CAN-06-3191.
4
Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients.受体酪氨酸激酶 Axl 表达水平较高,其配体 Gas6 表达存在差异,提示肺腺癌患者的生存预后较差。
Ann Surg Oncol. 2013 Dec;20 Suppl 3(Suppl 3):S467-76. doi: 10.1245/s10434-012-2795-3. Epub 2012 Dec 16.
5
The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target.Axl受体酪氨酸激酶在胰腺癌中具有不良预后影响,是一个新的治疗靶点。
Cancer Biol Ther. 2009 Apr;8(7):618-26. doi: 10.4161/cbt.8.7.7923. Epub 2009 Apr 22.
6
AXL is a potential target for therapeutic intervention in breast cancer progression.AXL是乳腺癌进展中治疗干预的潜在靶点。
Cancer Res. 2008 Mar 15;68(6):1905-15. doi: 10.1158/0008-5472.CAN-07-2661.
7
YES-associated protein 1 promotes adenocarcinoma growth and metastasis through activation of the receptor tyrosine kinase Axl.YES 相关蛋白 1 通过激活受体酪氨酸激酶 Axl 促进腺癌生长和转移。
Int J Immunopathol Pharmacol. 2012 Oct-Dec;25(4):989-1001. doi: 10.1177/039463201202500416.
8
Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas.Axl 激酶驱动肺腺癌中的免疫检查点和趋化因子信号通路。
Mol Cancer. 2019 Feb 11;18(1):24. doi: 10.1186/s12943-019-0953-y.
9
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.Axl受体酪氨酸激酶的显性负性抑制可抑制脑肿瘤细胞的生长和侵袭并延长生存期。
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5799-804. doi: 10.1073/pnas.0510923103. Epub 2006 Apr 3.
10
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma.Axl 受体酪氨酸激酶是食管腺癌的不良预后因素和治疗靶点。
Cancer Biol Ther. 2010 Nov 15;10(10):1009-18. doi: 10.4161/cbt.10.10.13248.

引用本文的文献

1
Atorvastatin exhibits anticancer effects by inhibiting YAP/TAZ activity in mesenchymal-like non-small cell lung cancer.阿托伐他汀通过抑制间充质样非小细胞肺癌中的YAP/TAZ活性发挥抗癌作用。
Sci Rep. 2025 Aug 18;15(1):30167. doi: 10.1038/s41598-025-15624-2.
2
A phase 1b, multicentre, dose escalation, safety and pharmacokinetics study of tilvestamab (BGB149) in relapsed, platinum-resistant, high-grade serous ovarian cancer (PROC) patients.一项关于替维司他单抗(BGB149)在复发、铂耐药、高级别浆液性卵巢癌(PROC)患者中的1b期、多中心、剂量递增、安全性和药代动力学研究。
Br J Cancer. 2025 Jul 22. doi: 10.1038/s41416-025-03090-6.
3
Recent advances in TAM mechanisms in lung diseases.肺部疾病中肿瘤相关巨噬细胞(TAM)机制的最新进展。
J Transl Med. 2025 Apr 26;23(1):479. doi: 10.1186/s12967-025-06398-2.
4
AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies.AXL作为急性髓系白血病中的免疫调节因子和治疗靶点:从当前进展到新策略
Exp Hematol Oncol. 2024 Oct 4;13(1):99. doi: 10.1186/s40164-024-00566-8.
5
AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy.AXL 表达反映了影响免疫检查点抑制剂单药治疗的非小细胞肺癌患者结局的肿瘤免疫细胞动态。
Front Immunol. 2024 Aug 21;15:1444007. doi: 10.3389/fimmu.2024.1444007. eCollection 2024.
6
Phase 1b study of batiraxcept in combination with durvalumab in patients with platinum-resistant ovarian cancer.巴替昔单抗联合度伐利尤单抗治疗铂耐药卵巢癌的1b期研究。
iScience. 2024 Apr 23;27(5):109801. doi: 10.1016/j.isci.2024.109801. eCollection 2024 May 17.
7
Tumor-associated macrophages affect the treatment of lung cancer.肿瘤相关巨噬细胞影响肺癌的治疗。
Heliyon. 2024 Apr 6;10(7):e29332. doi: 10.1016/j.heliyon.2024.e29332. eCollection 2024 Apr 15.
8
Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma.AXL 受体酪氨酸激酶信号通路参与胶质母细胞瘤的发病机制。
Cells. 2024 Feb 19;13(4):361. doi: 10.3390/cells13040361.
9
MiR-34a functions as a tumor suppressor in oral cancer through the inhibition of the Axl/Akt/GSK-3β pathway.微小RNA-34a通过抑制Axl/Akt/糖原合成酶激酶-3β信号通路在口腔癌中发挥抑癌作用。
J Dent Sci. 2024 Jan;19(1):428-437. doi: 10.1016/j.jds.2023.08.013. Epub 2023 Aug 25.
10
Nuclear translocation of Axl contributes to the malignancy of oral cancer cells.Axl的核转位促进口腔癌细胞的恶性程度。
J Dent Sci. 2024 Jan;19(1):438-447. doi: 10.1016/j.jds.2023.08.014. Epub 2023 Aug 29.

本文引用的文献

1
Role of Gas6/Axl signaling in lens epithelial cell proliferation and survival.Gas6/Axl信号通路在晶状体上皮细胞增殖与存活中的作用。
Exp Eye Res. 2004 Jan;78(1):27-37. doi: 10.1016/j.exer.2003.10.002.
2
Tumor-associated antigen L6 and the invasion of human lung cancer cells.肿瘤相关抗原L6与人类肺癌细胞的侵袭
Clin Cancer Res. 2003 Jul;9(7):2807-16.
3
Collapsin response mediator protein-1: a novel invasion-suppressor gene.塌陷反应介导蛋白-1:一种新型的侵袭抑制基因。
Clin Exp Metastasis. 2003;20(1):69-76. doi: 10.1023/a:1022598604565.
4
Clinical significance of AXL kinase family in gastric cancer.AXL激酶家族在胃癌中的临床意义
Anticancer Res. 2002 Mar-Apr;22(2B):1071-8.
5
Expression profile of tyrosine kinases in breast cancer.乳腺癌中酪氨酸激酶的表达谱
Clin Cancer Res. 2002 Feb;8(2):361-7.
6
Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion.Axl受体酪氨酸激酶在人肺癌细胞系中的表达与细胞黏附相关。
Eur J Cancer. 2001 Nov;37(17):2264-74. doi: 10.1016/s0959-8049(01)00271-4.
7
Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breast.受体酪氨酸激酶axl在正常和恶性人乳腺中的雌激素依赖性表达。
Ann Oncol. 2001 Jun;12(6):819-24. doi: 10.1023/a:1011126330233.
8
The hallmarks of cancer.癌症的特征
Cell. 2000 Jan 7;100(1):57-70. doi: 10.1016/s0092-8674(00)81683-9.
9
Comparative tyrosine-kinase profiles in colorectal cancers: enhanced arg expression in carcinoma as compared with adenoma and normal mucosa.结直肠癌中酪氨酸激酶谱的比较:与腺瘤和正常黏膜相比,癌组织中arg表达增强。
Int J Cancer. 1999 Nov 26;83(5):579-84. doi: 10.1002/(sici)1097-0215(19991126)83:5<579::aid-ijc1>3.0.co;2-r.
10
Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK).在初发急性髓系白血病(AML)中,Axl表达与不良预后以及Bcl-2和CD34的表达相关:来自瑞士临床癌症研究组(SAKK)的一项多中心试验结果
Leukemia. 1999 Sep;13(9):1352-8. doi: 10.1038/sj.leu.2401484.

轴突受体酪氨酸激酶(axl)在肺腺癌中的表达及其与肿瘤进展的相关性。

Expression of axl in lung adenocarcinoma and correlation with tumor progression.

作者信息

Shieh Yi-Shing, Lai Chiung-Ya, Kao Yu-Rung, Shiah Shine-Gwo, Chu Yi-Wen, Lee Herng-Sheng, Wu Cheng-Wen

机构信息

School of Dentistry, National Defense Medical Center, Taipei, Taiwan, ROC.

出版信息

Neoplasia. 2005 Dec;7(12):1058-64. doi: 10.1593/neo.05640.

DOI:10.1593/neo.05640
PMID:16354588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1501169/
Abstract

We used the Transwell system to select highly invasive cell lines from minimally invasive parent cells, and we compared gene expression in paired cell lines with high and low invasive potentials. Axl was relatively overexpressed in the highly invasive cell lines when compared with their minimally invasive counterparts. However, there is only limited information about the role of Axl in cancer invasion. The biologic function of Axl in tumor invasion was investigated by overexpression of full-length Axl in minimally invasive cells and by siRNA knockdown of Axl expression in highly invasive cells. Overexpression of Axl in minimally invasive cells increased their invasiveness. siRNA reduced cell invasiveness as Axl was downregulated in highly invasive cells. We further investigated the protein expression of Axl by immunohistochemistry and its correlation with clinicopathologic features. Data from a study of 58 patient specimens showed that Axl immunoreactivity was statistically significant with respect to lymph node status (P < .0001) and the patient's clinical stage (P < .0001). Our results demonstrate that Axl protein kinase seems to play an important role in the invasion and progression of lung cancer.

摘要

我们使用Transwell系统从微创亲本细胞中筛选出高侵袭性细胞系,并比较了具有高侵袭潜能和低侵袭潜能的配对细胞系中的基因表达。与微创对应细胞系相比,Axl在高侵袭性细胞系中相对过表达。然而,关于Axl在癌症侵袭中的作用的信息有限。通过在微创细胞中过表达全长Axl以及在高侵袭性细胞中通过小干扰RNA(siRNA)敲低Axl表达,研究了Axl在肿瘤侵袭中的生物学功能。在微创细胞中过表达Axl增加了它们的侵袭性。当Axl在高侵袭性细胞中被下调时,siRNA降低了细胞侵袭性。我们通过免疫组织化学进一步研究了Axl的蛋白表达及其与临床病理特征的相关性。对58例患者标本的研究数据表明,Axl免疫反应性在淋巴结状态(P < .0001)和患者临床分期(P < .0001)方面具有统计学意义。我们的结果表明,Axl蛋白激酶似乎在肺癌的侵袭和进展中起重要作用。